A consumer class action lawsuit was filed against Quincy Bioscience, and further, their Prevagen supplement, in August 2018. The Prevagen lawsuit alleges that Quincy falsely marketed its supplement Prevagen as being clinically tested to improve memory within 90 days and support healthy brain function, sharper mind, and clearer thinking. In short, plaintiffs claim that the supplement has not been clinically tested and does not provide the advertised brain and memory benefits. A full copy of the Prevagen Class Action Lawsuit is below:
Editor’s note on the Prevagen Class Action Lawsuit:
This piece is written about the recent Prevagen Lawsuit. If you are considered eligible to be among the class of consumers described in the class action, you may eventually be able to participate in receiving any compensation the court may award.
If you believe that what is alleged in the Prevagen class action has affected you, please don’t hesitate to reach out to us. We’d be happy to help you take a step in the right direction, fight this issue, and better enable you to join the consumer class action. If interested, please send an email to Outreach@ConsiderTheConsumer.com, find us on Twitter, Facebook, Instagram, LinkedIn, or even connect with us directly on our website! We look forward to hearing from all of you.
The case can be searched for under the name: Spath et al v. Quincy Bioscience Holding Company, Inc. et al, Case No. 18-cv-12416, D. NJ.